Medpace Holdings Stock Total Debt

MEDP Stock

USD 337.82 0.07 0.02%

Medpace Holdings fundamentals help investors to digest information that contributes to Medpace Holdings' financial success or failures. It also enables traders to predict the movement of Medpace Stock. The fundamental analysis module provides a way to measure Medpace Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medpace Holdings stock.

Short Long Term Debt Total Total Assets

As of 11/26/2024, Total Debt To Capitalization is likely to grow to 0.13.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Medpace Holdings Company Total Debt Analysis

Medpace Holdings' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Total Debt

Bonds

+

Notes

More About Total Debt | All Equity Analysis

Current Medpace Holdings Total Debt

142.12 M

Most of Medpace Holdings' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medpace Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Medpace Total Debt Driver Correlations

Understanding the fundamental principles of building solid financial models for Medpace Holdings is extremely important. It helps to project a fair market value of Medpace Stock properly, considering its historical fundamentals such as Total Debt. Since Medpace Holdings' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Medpace Holdings' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Medpace Holdings' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Short Term Investments	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.54	0.42	0.81	-0.69	-0.02	0.74	-0.5	0.81	-0.42	-0.45	0.68	0.11	-0.38	0.95	0.76	-0.56	-0.22	0.81	-0.53	0.7	-0.03	-0.23	-0.47
Total Stockholder Equity	0.54		0.92	0.4	-0.91	0.53	0.56	-0.72	0.41	-0.22	-0.58	-0.24	0.48	-0.68	0.75	0.54	-0.7	0.49	0.52	-0.72	0.59	0.48	0.39	0.0
Net Tangible Assets	0.42	0.92		0.28	-0.86	0.49	0.61	-0.75	0.42	0.06	-0.59	-0.32	0.52	-0.73	0.67	0.31	-0.73	0.66	0.53	-0.78	0.59	0.45	0.39	0.17
Current Deferred Revenue	0.81	0.4	0.28		-0.7	-0.47	0.85	-0.71	0.89	-0.77	-0.57	0.58	0.01	-0.6	0.76	0.91	-0.77	-0.35	0.84	-0.67	0.84	-0.5	-0.64	-0.86
Net Debt	-0.69	-0.91	-0.86	-0.7		-0.16	-0.82	0.91	-0.72	0.43	0.71	0.0	-0.38	0.85	-0.86	-0.75	0.91	-0.32	-0.77	0.9	-0.86	-0.11	-0.01	0.31
Retained Earnings	-0.02	0.53	0.49	-0.47	-0.16		-0.3	0.15	-0.4	0.46	0.14	-0.48	0.4	0.16	0.13	-0.23	0.19	0.51	-0.25	0.1	-0.31	0.96	0.96	0.74
Accounts Payable	0.74	0.56	0.61	0.85	-0.82	-0.3		-0.88	0.95	-0.4	-0.7	0.38	0.28	-0.81	0.82	0.71	-0.93	0.05	0.95	-0.89	0.95	-0.33	-0.44	-0.53
Long Term Debt	-0.5	-0.72	-0.75	-0.71	0.91	0.15	-0.88		-0.77	0.44	0.78	0.05	-0.3	0.97	-0.68	-0.66	0.98	-0.35	-0.78	0.98	-0.93	0.21	0.26	0.43
Net Receivables	0.81	0.41	0.42	0.89	-0.72	-0.4	0.95	-0.77		-0.46	-0.62	0.58	0.12	-0.67	0.82	0.76	-0.81	-0.11	0.96	-0.8	0.92	-0.45	-0.56	-0.61
Good Will	-0.42	-0.22	0.06	-0.77	0.43	0.46	-0.4	0.44	-0.46		0.31	-0.3	0.14	0.38	-0.36	-0.85	0.47	0.46	-0.39	0.32	-0.51	0.47	0.55	0.88
Short Term Investments	-0.45	-0.58	-0.59	-0.57	0.71	0.14	-0.7	0.78	-0.62	0.31		-0.02	-0.26	0.77	-0.57	-0.52	0.74	-0.26	-0.63	0.82	-0.78	0.16	0.2	0.33
Total Liab	0.68	-0.24	-0.32	0.58	0.0	-0.48	0.38	0.05	0.58	-0.3	-0.02		-0.29	0.15	0.45	0.41	-0.05	-0.68	0.49	0.01	0.29	-0.45	-0.6	-0.55
Deferred Long Term Liab	0.11	0.48	0.52	0.01	-0.38	0.4	0.28	-0.3	0.12	0.14	-0.26	-0.29		-0.25	0.25	0.11	-0.3	0.31	0.33	-0.34	0.18	0.25	0.31	0.23
Short Long Term Debt	-0.38	-0.68	-0.73	-0.6	0.85	0.16	-0.81	0.97	-0.67	0.38	0.77	0.15	-0.25		-0.57	-0.55	0.95	-0.46	-0.68	0.95	-0.89	0.17	0.22	0.36
Total Current Assets	0.95	0.75	0.67	0.76	-0.86	0.13	0.82	-0.68	0.82	-0.36	-0.57	0.45	0.25	-0.57		0.76	-0.72	0.03	0.85	-0.71	0.79	0.1	-0.07	-0.34
Short Term Debt	0.76	0.54	0.31	0.91	-0.75	-0.23	0.71	-0.66	0.76	-0.85	-0.52	0.41	0.11	-0.55	0.76		-0.71	-0.3	0.73	-0.61	0.76	-0.28	-0.4	-0.75
Intangible Assets	-0.56	-0.7	-0.73	-0.77	0.91	0.19	-0.93	0.98	-0.81	0.47	0.74	-0.05	-0.3	0.95	-0.72	-0.71		-0.23	-0.82	0.96	-0.94	0.23	0.3	0.48
Common Stock	-0.22	0.49	0.66	-0.35	-0.32	0.51	0.05	-0.35	-0.11	0.46	-0.26	-0.68	0.31	-0.46	0.03	-0.3	-0.23		-0.03	-0.39	0.15	0.5	0.55	0.59
Property Plant Equipment	0.81	0.52	0.53	0.84	-0.77	-0.25	0.95	-0.78	0.96	-0.39	-0.63	0.49	0.33	-0.68	0.85	0.73	-0.82	-0.03		-0.81	0.9	-0.32	-0.43	-0.51
Long Term Debt Total	-0.53	-0.72	-0.78	-0.67	0.9	0.1	-0.89	0.98	-0.8	0.32	0.82	0.01	-0.34	0.95	-0.71	-0.61	0.96	-0.39	-0.81		-0.93	0.17	0.22	0.34
Capital Surpluse	0.7	0.59	0.59	0.84	-0.86	-0.31	0.95	-0.93	0.92	-0.51	-0.78	0.29	0.18	-0.89	0.79	0.76	-0.94	0.15	0.9	-0.93		-0.33	-0.44	-0.56
Net Invested Capital	-0.03	0.48	0.45	-0.5	-0.11	0.96	-0.33	0.21	-0.45	0.47	0.16	-0.45	0.25	0.17	0.1	-0.28	0.23	0.5	-0.32	0.17	-0.33		0.97	0.75
Net Working Capital	-0.23	0.39	0.39	-0.64	-0.01	0.96	-0.44	0.26	-0.56	0.55	0.2	-0.6	0.31	0.22	-0.07	-0.4	0.3	0.55	-0.43	0.22	-0.44	0.97		0.84
Capital Stock	-0.47	0.0	0.17	-0.86	0.31	0.74	-0.53	0.43	-0.61	0.88	0.33	-0.55	0.23	0.36	-0.34	-0.75	0.48	0.59	-0.51	0.34	-0.56	0.75	0.84

Click cells to compare fundamentals

Medpace Total Debt Historical Pattern

Today, most investors in Medpace Holdings Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Medpace Holdings' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total debt growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Medpace Holdings total debt as a starting point in their analysis.

Medpace Holdings Total Debt

Timeline

In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.

Competition

Predict Medpace Holdings

Short Long Term Debt Total Over Time

Medpace Short Long Term Debt Total

Short Long Term Debt Total

173.93 Million

At this time, Medpace Holdings' Short and Long Term Debt Total is relatively stable compared to the past year.

Based on the latest financial disclosure, Medpace Holdings has a Total Debt of 142.12 M. This is 94.83% lower than that of the Life Sciences Tools & Services sector and 84.7% lower than that of the Health Care industry. The total debt for all United States stocks is 97.33% higher than that of the company.

Medpace Total Debt Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medpace Holdings' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medpace Holdings could also be used in its relative valuation, which is a method of valuing Medpace Holdings by comparing valuation metrics of similar companies.

Medpace Holdings is currently under evaluation in total debt category among its peers.

Medpace Holdings ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Medpace Holdings' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Medpace Holdings' managers, analysts, and investors.

Environmental

Governance

Social

Medpace Holdings Institutional Holders

Institutional Holdings refers to the ownership stake in Medpace Holdings that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Medpace Holdings' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Medpace Holdings' value.

		Shares
Bessemer Group Inc	2024-06-30	484.5 K
Findlay Park Partners Llp	2024-09-30	470.9 K
Capital World Investors	2024-09-30	438.4 K
Clearbridge Advisors, Llc	2024-09-30	417.9 K
Td Global Investment Solutions – Td Epoch	2024-09-30	416.2 K
American Capital Management Inc	2024-09-30	380.6 K
Aqr Capital Management Llc	2024-06-30	310.6 K
Wellington Management Company Llp	2024-06-30	305.4 K
Norges Bank	2024-06-30	279.6 K
Blackrock Inc	2024-06-30	2.6 M
Vanguard Group Inc	2024-09-30	2.5 M

Medpace Fundamentals

	Return On Equity	0.54
	Return On Asset	0.14
	Profit Margin	0.18 %
	Operating Margin	0.21 %
	Current Valuation	9.97 B
	Shares Outstanding	31.08 M
	Shares Owned By Insiders	17.70 %
	Shares Owned By Institutions	85.99 %
	Number Of Shares Shorted	1.1 M
	Price To Earning	49.07 X
	Price To Book	11.91 X
	Price To Sales	5.07 X
	Revenue	1.89 B
	Gross Profit	925.11 M
	EBITDA	363.15 M
	Net Income	282.81 M
	Cash And Equivalents	31.01 M
	Cash Per Share	1.00 X
	Total Debt	142.12 M
	Debt To Equity	0.85 %
	Current Ratio	0.41 X
	Book Value Per Share	28.42 X
	Cash Flow From Operations	433.37 M
	Short Ratio	2.87 X
	Earnings Per Share	11.42 X
	Price To Earnings To Growth	1.61 X
	Target Price	349.82
	Number Of Employees	5.9 K
	Beta	1.37
	Market Capitalization	10.5 B
	Total Asset	1.66 B
	Retained Earnings	(221.65 M)
	Working Capital	(331.3 M)
	Current Asset	94.72 M
	Current Liabilities	134.02 M
	Net Asset	1.66 B

About Medpace Holdings Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Medpace Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medpace Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medpace Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Medpace Holdings

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medpace Holdings position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medpace Holdings will appreciate offsetting losses from the drop in the long position's value.

Moving against Medpace Stock

0.38	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.33	EWTX	Edgewise Therapeutics	Pair Corr
0.32	FLGC	Flora Growth Corp	Pair Corr

The ability to find closely correlated positions to Medpace Holdings could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medpace Holdings when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medpace Holdings - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medpace Holdings to buy it.

The correlation of Medpace Holdings is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medpace Holdings moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medpace Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Medpace Holdings can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Medpace Stock Analysis

When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC